Navigation Links
IGF-1 and Long IGF-1 LR3 Is There a Difference? US Peptides Discusses
Date:2/8/2013

TAMPA, Fla., Feb. 8, 2013 /PRNewswire-iReach/ -- Research peptides are used around the world for a number of reason but most notably to test the effects of growth hormone related hormones and growth hormone related peptides and their effects.

(Photo: http://photos.prnewswire.com/prnh/20130208/CG56993)

US Peptides carries a variety of products such as: Melanotan II, CJC-1295, GHRP-6, Sermorelin, IGF1-LR3, GHRP-2, Fragment 176-191, CJC-1295 DAC, Mechano Growth Factor – PEG, Mechano Growth Factor, Hexarelin, Ipamorelin, Melanotan I, Bacteriostatic 0.9% Sodium Chloride and hard to find Bacteriostatic Water.

Growth factors like IGF play an important role in childhood, specifically puberty. IGF is responsible for natural muscle growth that occurs during puberty, along with other functions like increased glucose transport, increased protein synthesis, increased RNA synthesis, increased amino acid transport to cells, and decreased protein degradation.

However, there are different forms of IGF, such as IGF-1 and IGF-1 LR3 that have varied potencies and functions.

IGF-1

Insulin-like Growth Factor 1, abbreviated IGF-1, is a protein that is encoded by the IGF1 gene. It consists of 70 amino acids and is a hormone that is structured similarly to insulin. Its main function is to stimulate growth within the body due to its regulation of both cell growth and cell death.

Synthetic IGF-1 serves as an alternative to solely relying on the pituitary gland to make Human Growth Hormone (HGH). The pituitary gland decreases function with age, but the IGF-1 bypasses that organ and produces the same effects of growth hormone.

IGF-1 Long R3

IGF-1 Long R3, or IGF-1 LR3, is a form of IGF that has been chemically altered with changed amino acids. It consists of 83 amino acids with a substation of Arg(R) for the Glu(E) at position three, hence, the name R3. The altercations enable it to avoid binding to proteins in the body, which allows it to have a longer half-life.

IGF-1 LR3 is more potent than the regular IGF-1 because of the decreased binding of Long R3 IGF-1 to IGF binding proteins. Its main purpose is to increase the biological activity of IGF.

Essentially, when IGF-1 LR3 is active in the body, it functions differently in different types of tissues. For instance, in muscle tissue, it makes the muscle more sensitive to insulin's effects, such as a reduction in fat storage. But while IGF-1 LR3 helps fat reduction, a person using it will experience weight gain because of the increase in pure-muscle weight.

Click this link to read more about IGF-1 and IGF-1 LR3

US Peptides is proud to offer high quality research grade peptides like IGF-1 LR3 for research purposes.

USPeptides.com is a United States based distributor of the highest grade research Peptides and Amino Acid Derivatives available. We utilize the most advanced techniques to ensure fast and secure product delivery. These items are intended for research purposes only.

To place an order or learn more please click here, 10% off any purchase of 10 items or more- http://uspeptides.com/



Media Contact: Don Pierce US Peptides LLC, 727-210-7821, info@useptides.com

News distributed by PR Newswire iReach: https://ireach.prnewswire.com


'/>"/>
SOURCE US Peptides LLC
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Theres a Robot Helping People who Suffer from Hip Pain
2. Are there HCG diet dangers? US HCG Injections Takes a Look.
3. US Peptides Increases Inventory on Sterile Bacteriostatic Water
4. Health Diagnostic Laboratory, Inc. (HDL, Inc.) Brings Advanced Testing to Capitol Hill, Discusses Health Care Cost Savings and Quality Improvement Potential
5. MDHI Provides Investor Update -- Provides Business Model Overview -- Discusses Upcoming Profitability
6. Dallas Car Wreck Lawyer Discusses Serious Consequences of Driving While Under the Influence of Drugs
7. Aethlon Medical Discusses Therapeutic Device Strategies to Address Cancer, Hepatitis-C and Sepsis with the Wall Street Transcript
8. Eaton Scientific Discusses Positive Anecdotal Feedback from Pharmacist Compounding Homatropine for Doctors Treating Patients Experiencing Hot Flash Symptoms in the Beverley Hills and Los Angeles Area.
9. US Vitamin Injections Discusses Bursitis Treatment with B12 Shots
10. Herborium(R) Group Discusses an Aftermath of the Ban of Diane-35 Acne Drug Due to Number of Deaths
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/12/2016)... 2016 (Kanadische ... http://www.sedar.com ) und der Website ... --> http://www.sedar.com ) und ... abrufbar.    --> Telesta ... Konzernabschluss des zweiten Quartals und die ...
(Date:2/12/2016)... 2016  Sequent Medical, Inc. gab heute bekannt, ... eine Studie zur Sicherheit und Wirksamkeit des WEB™-Systems ... Behandlung von rupturierten intrakraniellen Aneurysmen begonnen hat. Prof. ... an der Universitätsklinik Bicètre in Paris ... den ersten Patienten aufgenommen. Im Rahmen ...
(Date:2/12/2016)... AUSTIN, Texas , Feb. 12, 2016 ... Institute for Robotic Surgery at St. David,s North Austin ... the da Vinci ® Xi ® Surgical ... ® 7000dV. Thiru Lakshman , M.D., ... performed a total proctocolectomy utilizing Integrated Table Motion technology, ...
Breaking Medicine Technology:
(Date:2/12/2016)... ... 12, 2016 , ... Erlanger Agency has announced a new partnership in its ... campaign focuses on the fight against breast cancer, fundraising for a local woman named ... . , Carmen is a loving single mother of two boys who also serves ...
(Date:2/12/2016)... , ... February 12, 2016 , ... Donor Network West, ... California and Nevada, announced a partnership with San Ramon Regional Medical Center. Under the ... hospital’s facilities as a way to accommodate a more certain time frame for donor ...
(Date:2/12/2016)... ... ... For Coast Dental dentist Everet Lake, DDS, the smiles began at dawn. ... before 7 a.m. to volunteer at Friday’s Dentistry from the Heart event in New ... help hundreds of uninsured and underinsured people receive much-needed dental care. , This ...
(Date:2/12/2016)... ... February 12, 2016 , ... Mediaplanet today announces the ... print component of “Revolutionizing Cancer Care” is distributed within the February 12 issue ... with a circulation of approximately 250,000 copies and an estimated readership of 750,000 ...
(Date:2/12/2016)... , ... February 12, 2016 , ... ... Drug Categories: Strategies for Health Plans and PBMs,” an upcoming Feb. 24 webinar ... affordability and access in big-dollar therapeutic categories, such as the $1,000-per-pill hepatitis C ...
Breaking Medicine News(10 mins):